FDA approves Alzheimer's drug to slow disease progression
By the end of this year, one Nebraska Medicine doctor says he hopes the hospital system will be able to provide a new Alzheimer's drug. It's called Leqembi, and it was FDA-approved last month. It's specifically for Alzheimer's.
Source: ketv.com